Furthermore, CD8 to Treg ratio, which correlates with a more favorable outcome in cancer [45, 46], was also correlated with T-cell richness (r = 0.68, p = 0.0012) and clonality (r = 0.64, p = 0.032) (Supplementary Fig. 8a-b). This evidence concerns the gene CD8A and cancer.